These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

170 related articles for article (PubMed ID: 24059369)

  • 1. Imatinib and beyond in gastrointestinal stromal tumors: A radiologist's perspective.
    Tirumani SH; Jagannathan JP; Krajewski KM; Shinagare AB; Jacene H; Ramaiya NH
    AJR Am J Roentgenol; 2013 Oct; 201(4):801-10. PubMed ID: 24059369
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Treatment response monitoring in patients with gastrointestinal stromal tumor using diffusion-weighted imaging: preliminary results in comparison with positron emission tomography/computed tomography.
    Gong NJ; Wong CS; Chu YC; Gu J
    NMR Biomed; 2013 Feb; 26(2):185-92. PubMed ID: 22806958
    [TBL] [Abstract][Full Text] [Related]  

  • 3. NCCN Task Force report: gastrointestinal stromal tumor (GIST).
    Demetri G; DeMatteo RP
    J Natl Compr Canc Netw; 2004 Sep; 2 Suppl 3():S-25-8. PubMed ID: 23570095
    [No Abstract]   [Full Text] [Related]  

  • 4. Management of gastrointestinal stromal tumor: the imatinib era and beyond.
    Parikh PM; Gupta S
    Indian J Cancer; 2013; 50(1):31-40. PubMed ID: 23713042
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Long-term follow-up outcome of imatinib mesylate treatment for recurrent and unresectable gastrointestinal stromal tumors.
    Saito S; Nakata K; Kajiura S; Ando T; Hosokawa A; Sugiyama T
    Digestion; 2013; 87(1):47-52. PubMed ID: 23343969
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Presentation and management of gastrointestinal stromal tumours.
    Mongan AM; Malik V; Rowley S; Claxton Z; Muldoon C; O'Toole D; Ravi N; Reynolds JV
    Ir Med J; 2013 Jun; 106(6):176-9. PubMed ID: 23909154
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Development and validation of prognostic nomograms for metastatic gastrointestinal stromal tumour treated with imatinib.
    Lee CK; Goldstein D; Gibbs E; Joensuu H; Zalcberg J; Verweij J; Casali PG; Maki RG; Cioffi A; Mcarthur G; Lord SJ; Yip D; Kanjanapan Y; Rutkowski P
    Eur J Cancer; 2015 May; 51(7):852-60. PubMed ID: 25801699
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Hepatic metastasis with heterologous rhabdomyoblastic differentiation in a patient with gastrointestinal stromal tumor treated with imatinib.
    Vij M; Patra S; Rela M
    Indian J Pathol Microbiol; 2013; 56(3):291-3. PubMed ID: 24152514
    [TBL] [Abstract][Full Text] [Related]  

  • 9. CT scan is not everything in the evaluation of a patient with gastrointestinal tumors (GIST) under imatinib therapy.
    Wang CM; Fu H; Zhao GF; Wang J; Shi YQ
    Pathol Oncol Res; 2012 Oct; 18(4):1095-7. PubMed ID: 21927980
    [No Abstract]   [Full Text] [Related]  

  • 10. [Two cases of recurrent GIST successfully treated with imatinib mesylate at 100mg/day].
    Hanada N; Kawata K; Okamura S; Tomiyama N; Hori K
    Gan To Kagaku Ryoho; 2013 Jun; 40(6):803-5. PubMed ID: 23863663
    [TBL] [Abstract][Full Text] [Related]  

  • 11. MiR-320a downregulation is associated with imatinib resistance in gastrointestinal stromal tumors.
    Gao X; Shen K; Wang C; Ling J; Wang H; Fang Y; Shi Y; Hou Y; Qin J; Sun Y; Qin X
    Acta Biochim Biophys Sin (Shanghai); 2014 Jan; 46(1):72-5. PubMed ID: 24217767
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Long-term efficacy of imatinib for treatment of metastatic GIST.
    Patel S
    Cancer Chemother Pharmacol; 2013 Aug; 72(2):277-86. PubMed ID: 23503753
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Gastrointestinal stromal tumour treated with neoadjuvant imatinib.
    Loughrey MB; Mitchell C; Mann GB; Michael M; Waring PM
    J Clin Pathol; 2005 Jul; 58(7):779-81. PubMed ID: 15976351
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Complete pathological response in advanced extra-gastrointestinal stromal tumor after imatinib mesylate therapy: a case report.
    Rediti M; Pellegrini E; Molinara E; Cerullo C; Fonte C; Lunghi A; Iori A; Neri B
    Anticancer Res; 2014 Feb; 34(2):905-7. PubMed ID: 24511030
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [Long-term survival in a case of recurrent gastrointestinal stromal tumor treated with intermittent or low-dose imatinib].
    Kurata Y; Takaishi S; Sakuma Y; Iwasaki K; Nimura Y; Tohma T; Kagaya A; Yamamoto Y; Matsubara H
    Gan To Kagaku Ryoho; 2014 Mar; 41(3):379-82. PubMed ID: 24743288
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Cost-effectiveness of 3-years of adjuvant imatinib in gastrointestinal stromal tumors (GIST) in the United States.
    Sanon M; Taylor DC; Parthan A; Coombs J; Paolantonio M; Sasane M
    J Med Econ; 2013; 16(1):150-9. PubMed ID: 22762291
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Nursing implications of imatinib as molecularly targeted therapy for gastrointestinal stromal tumors.
    Griffin JM; Amand MS; Demetri GD
    Clin J Oncol Nurs; 2005 Apr; 9(2):161-9. PubMed ID: 15853160
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Current directions in systemic therapy for gastrointestinal stromal tumors.
    Chugh R
    Curr Probl Cancer; 2011; 35(5):255-70. PubMed ID: 22118565
    [No Abstract]   [Full Text] [Related]  

  • 19. Gastrointestinal stromal tumor of the rectum: results of surgical and multimodality therapy in the era of imatinib.
    Jakob J; Mussi C; Ronellenfitsch U; Wardelmann E; Negri T; Gronchi A; Hohenberger P
    Ann Surg Oncol; 2013 Feb; 20(2):586-92. PubMed ID: 22965573
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Gastrointestinal stromal tumor: new nodule-within-a-mass pattern of recurrence after partial response to imatinib mesylate.
    Shankar S; vanSonnenberg E; Desai J; Dipiro PJ; Van Den Abbeele A; Demetri GD
    Radiology; 2005 Jun; 235(3):892-8. PubMed ID: 15833985
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.